NPS PHARMACEUTICALS INC Selling, General and Administrative Expense
NPS PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $114.25 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2015-02-18
- NPS PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-12-31 was $35.11M, a 60.76% increase year-over-year.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-09-30 was $28.14M, a 60.26% increase year-over-year.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-06-30 was $26.45M, a 82.85% increase year-over-year.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2014-03-31 was $24.55M, a 72.85% increase year-over-year.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2014 was $114.25M, a 67.85% increase from fiscal 2013.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2013 was $68.07M, a 84.33% increase from fiscal 2012.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2012 was $36.93M, a 52.44% increase from fiscal 2011.
- NPS PHARMACEUTICALS INC selling, general and administrative expense for fiscal 2011 was $24.23M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | $35.11M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $63.25M derived: sum of 2 quarters · filed 2015-02-18 | $89.70M derived: sum of 3 quarters · filed 2015-02-18 | $114.25M 10-K · filed 2015-02-18 |
| 2014-09-30 | $28.14M 10-Q · filed 2014-11-10 | $54.59M derived: sum of 2 quarters · filed 2014-11-10 | $79.14M 10-Q · filed 2014-11-10 | $100.98M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-06-30 | $26.45M 10-Q · filed 2014-08-06 | $51.00M 10-Q · filed 2014-08-06 | $72.84M derived: sum of 3 quarters · filed 2015-02-18 | $90.40M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-03-31 | $24.55M 10-Q · filed 2014-05-08 | $46.40M derived: sum of 2 quarters · filed 2015-02-18 | $63.95M derived: sum of 3 quarters · filed 2015-02-18 | $78.42M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-12-31 | $21.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $39.40M derived: sum of 2 quarters · filed 2015-02-18 | $53.87M derived: sum of 3 quarters · filed 2015-02-18 | $68.07M 10-K · filed 2015-02-18 |
| 2013-09-30 | $17.56M 10-Q · filed 2014-11-10 | $32.02M derived: sum of 2 quarters · filed 2014-11-10 | $46.23M 10-Q · filed 2014-11-10 | $57.39M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $14.46M 10-Q · filed 2014-08-06 | $28.67M 10-Q · filed 2014-08-06 | $39.83M derived: sum of 3 quarters · filed 2015-02-18 | $48.16M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $14.21M 10-Q · filed 2014-05-08 | $25.36M derived: sum of 2 quarters · filed 2015-02-18 | $33.69M derived: sum of 3 quarters · filed 2015-02-18 | $43.36M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $19.49M derived: sum of 2 quarters · filed 2015-02-18 | $29.16M derived: sum of 3 quarters · filed 2015-02-18 | $36.93M 10-K · filed 2015-02-18 |
| 2012-09-30 | $8.33M 10-Q · filed 2013-11-06 | $18.00M derived: sum of 2 quarters · filed 2013-11-06 | $25.77M 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $9.67M 10-Q · filed 2013-08-08 | $17.44M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $7.77M 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | $24.23M 10-K · filed 2014-02-18 |